Hovid Pharma Limited
Summary
Hovid Pharma Limited was set up on Tuesday the 22nd of February 2022. Their current partial address is Harcourt Road, and the company status is Normal. The company's current directors have been the director of 0 other Irish companies between them. Hovid Pharma Limited has 1 shareholder. This Irish company shares its Eircode with at least 351 other companies.
Credit Score
- Latest Credit Movement:
- Date of Last Movement:13/06/2024
- Latest Accounts Filed:26/02/2024
- Report Based On Accounts:30/06/2023
- Next Set of Accounts Due:22/02/2025
- Overdue:No
Credit Report
- Credit Report & Financials
- Company Printout Report
- Directors & Owners Report
- Bad Debt Judgments Report
- Mortgages Report
€9
Company Vitals
- Company Name:Hovid Pharma Limited
- Time in Business:2 Years
- Company Number:714264
- Company Size:Micro Company
- Current Status:NORMAL
- Principal Activity:[4646] Wholesale of Pharmaceutical Goods
- May Trade As:Hovid Pharma Ltd
- Registered Address:Block 3,
Harcourt Centre,
Harcourt Road,
, Ireland
D02 A339
€3
Directors
Purchase either the Standard Company Report or a Credit Report to view details on the directors of this company.
Judgments
Discover poor payment histories of any company by searching our Judgment Database, for court actions brought against a company for non-payment of a debt. Plus get free Judgment monitoring alerts on this company for the next 12 months. Judgments are available as part of the Credit Report.
Judgment Report:
Search all Registered Bad Debt Judgments for Co. Name matches.
€5
Documents
Document | Pages | Effective | Received | Buy |
---|---|---|---|---|
NEW! Form B2: Change of Company Registered Office Address | 2 | 01/11/2024 | 11/11/2024 | |
B10 CHANGE IN DIRECTORS/SECRETARY | 3 | 24/07/2024 | 16/08/2024 | |
OTHER DIRECTORSHIP LIST | 4 | 22/02/2024 | 28/03/2024 | |
Form B1B - Replacement Annual Return | 4 | 22/02/2024 | 28/03/2024 | |
FINANCIAL STATEMENT | 15 | 22/02/2024 | 26/02/2024 | |
Certificate of Incorporation | 1 | 22/02/2022 | 16/02/2022 |